Search Results for keywords:"legal procedure"

Found 6 results
Skip to main content

Search Results: keywords:"legal procedure"

  • Type:Notice
    Citation:89 FR 101600
    Reading Time:about 2 minutes

    The Federal Energy Regulatory Commission (FERC) announced that it started an investigation to assess if CPV Shore, LLC's rate schedule is unjust or discriminatory, according to section 206 of the Federal Power Act. As of December 16, 2024, the refund effective date aligns with the notice's publication in the Federal Register. Interested parties who wish to intervene in Docket No. EL25-31-000 must submit their notices or motions within 21 days of the original order's issuance, maintaining compliance with FERC's procedures. FERC encourages electronic submissions and is providing support for the public to access related documents through their website.

    Simple Explanation

    The government is checking if CPV Shore, LLC is charging fair prices for electricity and will give back any extra money if needed. People who want to join the discussion must do so soon, mostly online, but some might find the instructions or the tech requirements a bit hard.

  • Type:Notice
    Citation:90 FR 10085
    Reading Time:about 8 minutes

    The Drug Enforcement Administration (DEA) sought to revoke two registrations of Jason Weakley, a registered nurse and advanced practice registered nurse, because he was not authorized to handle controlled substances in Vermont and New Hampshire. Weakley's nursing licenses in both states had expired and remained suspended. He was informed of his right to a hearing but did not request one, leading to a default judgment against him. Consequently, the DEA revoked his registrations, preventing him from handling controlled substances and from renewing or applying for new registrations in these states.

    Simple Explanation

    Jason, a nurse, had his permissions taken away by a government agency because he wasn't allowed to work with special medicines in Vermont and New Hampshire anymore since his nurse licenses expired. He didn't ask for a talk about it, so they decided he couldn't handle these medicines now or try to get new permissions in those states.

  • Type:Notice
    Citation:90 FR 12174
    Reading Time:about 3 minutes

    The U.S. International Trade Commission decided not to review a decision made by an administrative law judge, which allowed Maxell, Ltd. to change their complaint in an investigation to include additional patent infringement claims against Samsung Electronics. Maxell argued that a previous oversight meant these claims were not initially included, and the judge agreed, noting that Samsung would not be significantly harmed because they were already aware of the claims. Samsung opposed the change, saying Maxell did not follow the correct procedure initially. No petitions to review the judge's decision were filed, and the Commission voted on March 10, 2025, to accept it without further review.

    Simple Explanation

    The U.S. International Trade Commission decided not to make a big fuss over a judge letting a company named Maxell add more complaints about another company, Samsung, that they say copied some of their ideas. The judge said adding these wasn’t a big deal since Samsung already knew about them, and nobody asked to change the judge’s mind, so everything stays as is.

  • Type:Notice
    Citation:90 FR 11988
    Reading Time:about 10 minutes

    The Food and Drug Administration (FDA) has issued an order permanently banning John Warrington Kosolcharoen from working with companies that have approved or pending drug product applications. This decision resulted from his felony conviction for fraudulently selling an unapproved stem cell product, ReGen, and making misleading claims about its safety and effectiveness. Mr. Kosolcharoen was given the chance to challenge the debarment but did not respond in the provided timeframe, leading to a waiver of his right to a hearing on the decision. During his debarment, any business that employs him for related services could also face penalties.

    Simple Explanation

    The FDA has decided that John Kosolcharoen can no longer work for companies that make or sell drugs because he was caught breaking the rules by selling a fake stem cell treatment, and when given a chance to explain himself, he didn't respond.

  • Type:Rule
    Citation:86 FR 7807
    Reading Time:about 3 minutes

    The Department of Labor (DOL) is correcting a previous rule that was published in the Federal Register on January 11, 2021. The rule required electronic filing and automatic acceptance of electronic service for representatives in proceedings before the Administrative Review Board, except with special permission. However, there was an error in the rule as it did not include instructions to revise two section headings in the Code of Federal Regulations, despite providing the new text for these sections. This correction adds the missing instructions to ensure the headings are revised as intended.

    Simple Explanation

    The Department of Labor fixed a small mistake in some rules about sending forms online. They forgot to update two titles in a big book of rules, so they added the missing instructions to fix it.

  • Type:Notice
    Citation:90 FR 3212
    Reading Time:about 3 minutes

    The Federal Deposit Insurance Corporation (FDIC) has announced the updated maximum civil money penalties, adjusted for inflation, applicable from January 15, 2025. These adjustments are guided by the Federal Civil Penalties Inflation Adjustment Act, which requires federal agencies to annually revise penalty amounts based on an inflation multiplier provided by the Office of Management and Budget. The penalties apply to violations occurring on or after November 2, 2015.

    Simple Explanation

    The FDIC has updated the amount of money people or companies can be fined if they break certain rules, so these fines now match how prices have changed over time. This update starts from January 15, 2025, and uses a special method to make sure the fines stay fair and reasonable.